Emetine and Its Derivatives as Anticancer Agents Targeting the PI3K/AKT/mTOR Pathway: A Narrative Review of Mechanisms, Pharmacology, and Clinical Insights.
- DOI
- 10.1111/jcmm.71328
- Published
- 2026 Aug
- Container
- Journal of cellular and molecular medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/jcmm.71328,
title = {Emetine and Its Derivatives as Anticancer Agents Targeting the PI3K/AKT/mTOR Pathway: A Narrative Review of Mechanisms, Pharmacology, and Clinical Insights.},
author = {Khatun MI and Selim S and Malik AH and Al Hasan MS and Khalipha ABR and Yana NT and Alshahrani MY and Hossain MA and Rakib IH and Chakrabarty A and Mia E},
year = {2026},
journal = {Journal of cellular and molecular medicine},
doi = {10.1111/jcmm.71328},
url = {https://doi.org/10.1111/jcmm.71328}
}RIS
TY - JOUR TI - Emetine and Its Derivatives as Anticancer Agents Targeting the PI3K/AKT/mTOR Pathway: A Narrative Review of Mechanisms, Pharmacology, and Clinical Insights. AU - Khatun MI AU - Selim S AU - Malik AH AU - Al Hasan MS AU - Khalipha ABR AU - Yana NT AU - Alshahrani MY AU - Hossain MA AU - Rakib IH AU - Chakrabarty A AU - Mia E PY - 2026 JO - Journal of cellular and molecular medicine DO - 10.1111/jcmm.71328 UR - https://doi.org/10.1111/jcmm.71328 ER -
APA
MI, K., S, S., AH, M., MS, A. H., ABR, K., NT, Y., MY, A., MA, H., IH, R., A, C., & E, M. (2026). Emetine and Its Derivatives as Anticancer Agents Targeting the PI3K/AKT/mTOR Pathway: A Narrative Review of Mechanisms, Pharmacology, and Clinical Insights.. Journal of cellular and molecular medicine. https://doi.org/10.1111/jcmm.71328
Source records
- pubmed · retrieved 2026-09-26T14:06:53.274Z